UP Xchange is Scitons signature leadership development experience, built on one powerful belief: every provider has Unfiltered Potential waiting to be unlocked
Researcher Inquiries Retatrutide (LY3437943) is a synthetic 39-amino acid peptide engineered as a triple receptor agonist targeting the GIP, GLP-1, and glucagon (GCG) receptors
Corrections to published data are recorded at finnrick.com/corrections
If you are experiencing new, worsening, or concerning symptoms while on a GLP-1 medication, confirm with a licensed clinician, especially if symptoms are persistent or affecting your daily life
For women, menstrual cycle changes that occurred during treatment, including increased fertility, heavier or lighter periods, or timing shifts, may continue changing after discontinuation